Kalera Public Limited Company - Warrant (NQ:KALWW)
Price and Volume
Detailed Quote| Volume | 0 | 
| Open | - | 
| Bid (Size) | 0.0060 (404) | 
| Ask (Size) | 0.0189 (29) | 
| Prev. Close | 0.0049 | 
| Today's Range | N/A - N/A | 
| 52wk Range | N/A - N/A | 
| Shares Outstanding | N/A | 
| Dividend Yield | N/A | 
Top News
More News
    KALERA PLC RECEIVES NOTICE OF DELISTING FROM NASDAQ
    
   
   
  April 10, 2023
   Performance
More News
Read More
    Kalera Outlines Additional Actions to Improve Profitability
    
   
   
  January 13, 2023
   
    Kalera Shareholders Approve Reverse Stock Split
    
   
   
  December 23, 2022
   
    Kalera Announces Restructuring Process for German Subsidiary
    
   
   
  November 28, 2022
   
    Kalera Announces Third Quarter 2022 Financial Results
    
   
   
  November 14, 2022
   
    Kalera Reports Preliminary Third Quarter 2022 Financial Results
    
   
   
  November 07, 2022
   
    Kalera to Release Third Quarter 2022 Earnings on November 14
    
   
   
  November 04, 2022
   
    Kalera to Divest Seed Genetics Business and International Assets
    
   
   
  October 18, 2022
   
    Kalera Engages Financial Profiles for Investor Relations
    
   
   
  July 25, 2022
   Frequently Asked Questions
Is Kalera Public Limited Company - Warrant publicly traded?
   Yes, Kalera Public Limited Company - Warrant is publicly traded.
  What exchange does Kalera Public Limited Company - Warrant trade on?
   Kalera Public Limited Company - Warrant trades on the Nasdaq Stock Market
  What is the ticker symbol for Kalera Public Limited Company - Warrant?
   The ticker symbol for Kalera Public Limited Company - Warrant is KALWW on the Nasdaq Stock Market
  
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

 
    
   